SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 325 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $202,000 | +47.4% | 1,829 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $137,000 | -17.5% | 1,829 | -13.9% | 0.00% | 0.0% |
| Q1 2022 | $166,000 | -23.5% | 2,124 | -11.1% | 0.00% | 0.0% |
| Q4 2021 | $217,000 | -25.9% | 2,389 | -24.5% | 0.00% | -50.0% |
| Q3 2021 | $293,000 | +7.3% | 3,166 | -9.9% | 0.00% | 0.0% |
| Q2 2021 | $273,000 | -75.1% | 3,512 | -76.1% | 0.00% | -71.4% |
| Q1 2021 | $1,096,000 | -55.0% | 14,712 | +2.8% | 0.01% | -58.8% |
| Q4 2020 | $2,436,000 | +5.9% | 14,305 | -12.7% | 0.02% | 0.0% |
| Q3 2020 | $2,300,000 | -19.4% | 16,377 | -8.0% | 0.02% | -26.1% |
| Q2 2020 | $2,855,000 | +33.9% | 17,800 | -18.3% | 0.02% | +109.1% |
| Q1 2020 | $2,132,000 | +46.2% | 21,800 | +92.9% | 0.01% | 0.0% |
| Q4 2019 | $1,458,000 | +321.4% | 11,300 | +145.7% | 0.01% | +266.7% |
| Q3 2019 | $346,000 | – | 4,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |